CELC

Celcuity Inc.
$82.58previous close on: 9/16/2026

Company Information

Company Name
Celcuity Inc.
CIK
CIK0001603454
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
CELC: Nasdaq
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
8071
SIC Description
Services-Medical Laboratories
Ticker
CELC

SEC filing data through

Insider Sentiment

Last purchase
2025-09-08
Last sale
2026-05-04
Shares purchased (TTM)
170,100
Shares sold (TTM)
89,325
Buy ratio (TTM)65.6%

Institutional Sentiment

As of
2026-03-31
Institutional shares owned
47,178,014
Shares outstanding
54,462,826
Ownership
86.62%
+15.11% Y/Y

Earnings Market Reaction

Filing date
2026-08-13
Price on filing date
1-month reaction
10.51%
3-month reaction
Pending
Drift continued9/11 (82%)
Faded / reversed2/11 (18%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets
Cash And Cash Equivalents At Carrying Value182145166744616231330313126
Short Term Investments572242276381122189213251253146150108
Assets Current
Assets Current776409466475183218245272292188191142
Other Prepaid Expense Current131519---7-----
Other Assets Current96521151238910108
Property Plant And Equipment Net110000000000
Intangible Assets Net Excluding Goodwill50-----------
Operating Lease Right Of Use Asset100000000000
Other Assets Noncurrent110---------
Assets828410467476184218245273293188191142
Liabilities And Stockholders Equity
Accounts Payable Current8106111110996556
Liabilities Current
Liabilities Current873344394033322620171413
Other Liabilities Current211421---5-----
Operating Lease Liability Current000000000000
Accrued Liabilities Current---2729232217131197
Operating Lease Liability Noncurrent1----0000000
Convertible Debt Noncurrent753196195195--------
Long Term Notes Payable-1281271259999989796383737
Preferred Stock Value------000000
Liabilities841357366359139131130123116545149
Common Stock Value000000000000
Stockholders Equity
Additional Paid In Capital568555549515398395387385382315300234
Stockholders Equity-1354101117448711615017713414093
Retained Earnings Accumulated Deficit-581-502-449-398-354-309-272-235-205-182-160-141
Liabilities And Stockholders Equity828410467476184218245273293188191142
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Preferred Stock Shares Authorized333333333333
Preferred Stock Shares Issued000000000111
Preferred Stock Shares Outstanding000000000111
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized959595959595956565656565
Common Stock Shares Issued494848433938373737312622
Shares Outstanding494848433938373737312622

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Celcuity Inc. (CELC) — SEC Financial Statements & Analysis

Celcuity Inc. (CELC) is a services-medical laboratories company, incorporated in DE. Celcuity Inc. trades on Nasdaq as: CELC. Celcuity Inc. (CELC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Celcuity Inc. carries a market cap of $5.73B, a P/E ratio of -25.32x, a P/B ratio of -448.70x, an enterprise value of $6.31B, and an EV/EBITDA multiple of -30.25x. On profitability, it posts a Return on Equity (ROE) of -1433.70%, a Return on Assets (ROA) of -44.77%, and a Return on Invested Capital (ROIC) of -63.65%. Per share, it reports EPS of $-4.13, diluted EPS of $-4.13, free cash flow per share of $-3.51, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 52.30% year-over-year and EPS growth of 21.31% year-over-year. On the balance sheet, it maintains a current ratio of 8.93x, a quick ratio of 8.93x, working capital of $688.97M, a debt-to-equity ratio of -65.80x, a debt ratio of 1.02, an interest coverage ratio of -9.37x, free cash flow of $-192.16M (TTM), and net debt of $571.19M. Figures sourced from SEC EDGAR.

Market Cap
$5.73B
P/E TTM
-25.32x
EPS TTM
$-4.13
P/B TTM
-448.70x
ROE TTM
-1433.70%
ROA TTM
-44.77%
Debt To Equity
-65.80x
Free Cash Flow TTM
$-192.16M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Celcuity Inc. in?

Celcuity Inc. (CELC) operates in the Services-Medical Laboratories industry.

What exchange does CELC trade on?

Celcuity Inc. (CELC) trades on the Nasdaq.

Where is Celcuity Inc. incorporated?

Celcuity Inc. is incorporated in DE.

When was Celcuity Inc. (CELC)'s most recent SEC filing?

Celcuity Inc. (CELC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.

What is CELC's market cap?

Celcuity Inc. (CELC) has a market capitalization of $5.73B as of 2026-06-30.

What is CELC's EPS (earnings per share)?

Celcuity Inc. (CELC)'s trailing twelve month EPS is $-4.13 as of 2026-06-30.

What is CELC's ROE (return on equity)?

Celcuity Inc. (CELC)'s trailing twelve month Return on Equity (ROE) is -1433.70% as of 2026-06-30.

What is CELC's ROA (return on assets)?

Celcuity Inc. (CELC)'s trailing twelve month Return on Assets (ROA) is -44.77% as of 2026-06-30.

What is CELC's ROIC (return on invested capital)?

Celcuity Inc. (CELC)'s trailing twelve month Return on Invested Capital (ROIC) is -63.65% as of 2026-06-30.

What is CELC's EV/EBITDA?

Celcuity Inc. (CELC)'s trailing twelve month EV/EBITDA is -30.25x as of 2026-06-30.

Wall Street's data.
Main Street's price.